Abstract
Pulmonary cell membranes form the first line of defense against respiratory viral infections and play an important role in modulating immune responses to airborne pathogens, such as the recent coronavirus (SARS-COV-2). Interestingly, common drugs, such as azithromycin and melatonin, have been reported as potential agents in slowing down and ameliorating the symptoms of respiratory viral infections, including SARS-COV-2. The generic effects of these drugs, across a range of viral infections, point to an indirect mechanism by which they inhibit viral activity - most likely by altering membrane properties and perturbing viral membrane-entry pathways.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
